Company: BrainCo Inc.
Headquarters: Boston, Massachusetts, USA
Founded: 2015
Funding: $100 million+ (Series B)
Status: Private
Website: brainco.tech
BrainCo is a neurotechnology company developing non-invasive brain-computer interfaces and neural interface technologies for both medical and consumer applications. The company focuses on wearable EEG-based devices that decode neural signals in real-time.
Founded in 2015 and headquartered in Boston, Massachusetts, BrainCo represents a leading player in the consumer neurotechnology space. The company's mission is to make brain-computer interface technology accessible to consumers, researchers, and medical professionals through affordable, non-invasive wearable devices.
Boston provides BrainCo with access to world-class research institutions including MIT, Harvard, and leading hospitals, as well as a vibrant biotechnology and technology ecosystem that supports innovation in neural interfaces.
¶ Company Background and History
BrainCo was founded with the vision of democratizing brain-computer interface technology. Unlike earlier BCI systems that required invasive surgery or expensive clinical equipment, BrainCo's approach uses non-invasive EEG technology that can be deployed in consumer-friendly form factors.
The company has grown from a startup focused on attention training to a diversified neurotechnology platform with applications spanning consumer wellness, education, medical rehabilitation, and advanced prosthetics.
BrainCo has raised over $100 million through multiple financing rounds:
- Seed funding: Initial product development
- Series A: Expansion of manufacturing and commercial operations
- Series B: Scaling clinical programs and new product development
BrainCo's technology platform centers on dry EEG sensor technology that eliminates the need for conductive gels required in traditional EEG systems. This breakthrough enables:
- Rapid setup and use
- Consumer-friendly form factors
- Portable and wearable designs
- Extended wear comfort
The company has developed sophisticated algorithms for:
- Real-time neural signal decoding
- Motion artifact removal
- Attention and meditation state detection
- Sleep stage classification
- Motor intention prediction
¶ Products and Applications
¶ Focus Headband
The Focus headband is BrainCo's flagship consumer product:
- Technology: Dry EEG sensors
- Target Users: Students, professionals seeking cognitive enhancement
- Features: Real-time attention tracking, meditation feedback
- Connectivity: Bluetooth to smartphone app
The Focus headband provides users with real-time feedback on their mental state, enabling training and improvement of attention and focus through neurofeedback techniques.
An educational version designed for classroom use:
- Attention tracking for students
- Teacher dashboards for classroom management
- Research-validated attention metrics
- Integration with educational platforms
BrainCo's prosthetic limb technology represents a significant advancement in neural prosthetics:
- Non-invasive EMG and EEG control
- Natural movement prediction
- Sensory feedback integration
- Clinical validation ongoing
This technology has particular relevance for patients who have lost limbs due to accident or disease, including those with neurodegenerative conditions that may affect motor function.
A consumer product line for mood and stress monitoring:
- Continuous stress tracking
- Mood pattern analysis
- Meditation and wellness guidance
- Integration with wearable ecosystems
BrainCo is actively expanding into medical device applications:
- FDA-cleared device for attention training in ADHD
- Clinically validated neurofeedback protocols
- Complementary to traditional ADHD treatments
- Insurance coverage expanding
- Brain-controlled rehabilitation devices
- Motor imagery-based therapy
- Integration with physical therapy programs
- Clinical trials demonstrating efficacy
- EEG-based sleep tracking
- Sleep stage analysis
- Sleep disorder screening
- Consumer and clinical applications
- Neural interfaces for advanced prosthetics
- Non-invasive alternatives to implanted electrodes
- Training systems for prosthetic use
- Research partnerships with leading rehabilitation centers
BrainCo maintains active research collaborations with leading institutions:
- MIT Media Lab: Collaborative research on neural interfaces
- Harvard Medical School: Stroke rehabilitation studies
- Stanford University: Brain-computer interface research
- Multiple university research programs
BrainCo's competitive advantages include:
- Non-invasive Technology: No surgery required, reducing risk and barriers to adoption
- Dry Sensors: No conductive gel needed, enabling rapid setup and portable use
- Real-time Processing: Low-latency neural decoding for responsive applications
- Affordable: Consumer price point compared to clinical systems
- Scalable Manufacturing: Proprietary sensor technology enables mass production
BrainCo technologies are particularly relevant for neurodegenerative disease research and management:
- Cognitive training and attention monitoring
- Early detection of cognitive decline through attention metrics
- Neurofeedback-based cognitive preservation
- Research applications in clinical trials
- Motor rehabilitation and tremor management
- Deep brain stimulation monitoring
- Movement disorder characterization
- Gait and balance training support
- Communication assistance for patients with limited mobility
- Eye-tracking integration for AAC devices
- Respiratory monitoring
- Quality of life improvements
- Fatigue monitoring and management
- Cognitive assessment tools
- Rehabilitation support
- Patient empowerment technologies
¶ Competitive Landscape
BrainCo operates in the growing neurotechnology market alongside:
- Emotiv (consumer EEG)
- Muse (meditation EEG)
- Advanced Brain Monitoring (clinical EEG)
- Kernel (neural recording)
BrainCo differentiates through its combination of medical-grade technology and consumer accessibility.
BrainCo continues to advance its technology platform through:
- Enhanced signal processing algorithms
- New sensor form factors
- Expanded clinical indications
- International market expansion
- Research partnerships for neurological applications